Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marie Jourdain"'
Autor:
Berangere Gapp, Marie Jourdain, Pauline Bringer, Benjamin Kueng, Delphine Weber, Arnaud Osmont, Stefan Zurbruegg, Judith Knehr, Rocco Falchetto, Guglielmo Roma, William Dietrich, Reginald Valdez, Nicolau Beckmann, Florian Nigsch, Arun J. Sanyal, Iwona Ksiazek
Publikováno v:
Hepatology Communications, Vol 4, Iss 1, Pp 109-125 (2020)
A promising approach for the treatment of nonalcoholic steatohepatitis (NASH) is the inhibition of enhanced hepatic de novo lipogenesis (DNL), which is the synthesis of fatty acids from nonlipid sources. This study assesses three approaches to DNL su
Externí odkaz:
https://doaj.org/article/f53881fedaa04196a137467b2582c5f6
Autor:
Marie Jourdain, Shinji Hatakeyama
Publikováno v:
BMC Research Notes, Vol 12, Iss 1, Pp 1-4 (2019)
Abstract Objective 5-HOB is a novel tissue selective, 5-hydroxybenzothiazolone-derived β2 adrenoceptor agonist with minimized cardiovascular effects while retaining efficacy on skeletal muscle in preclinical experiments unlike conventional β2 adren
Externí odkaz:
https://doaj.org/article/7ffee8f1cfa54ccfb1fca1c3bc5c897d
Autor:
Florian Nigsch, Rocco Falchetto, Nicolau Beckmann, Guglielmo Roma, Iwona Ksiazek, William F. Dietrich, Marie Jourdain, Delphine Weber, Pauline Bringer, Arun J. Sanyal, Berangere Gapp, Benjamin Kueng, Stefan Zurbruegg, Judith Knehr, Reginald Valdez, Arnaud Osmont
Publikováno v:
Hepatology Communications, Vol 4, Iss 1, Pp 109-125 (2020)
A promising approach for the treatment of nonalcoholic steatohepatitis (NASH) is the inhibition of enhanced hepatic de novo lipogenesis (DNL), which is the synthesis of fatty acids from nonlipid sources. This study assesses three approaches to DNL su
Autor:
Dean F. Rigel, Berengere Dumotier, Brian Peter Richardson, Thomas Ullrich, Moise Azria, Estelle Lach-Trifilieff, Shinji Hatakeyama, David J. Glass, Julian Bösch, David A. Sykes, Michael Kiffe, Ngoc-Hong Nguyen, Jeffrey Tsao, Steven J. Charlton, Magdalena Koziczak-Holbro, Robin Alec Fairhurst, Marie Jourdain, Ludivine Flotte, Yuichiro Adachi
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 369:188-199
The anabolic effects of β2-adrenoceptor (β2-AR) agonists on skeletal muscle have been demonstrated in various species. However, the clinical use of β2-AR agonists for skeletal muscle wasting conditions has been limited by their undesired cardiovas
Publikováno v:
Biochemical and Biophysical Research Communications. 503:2415-2420
The majority of patients with advanced cancer suffer from cachexia, a systemic wasting syndrome, which subsequently impacts the tolerance to anti-cancer treatments, response to therapy, quality of life, and eventually, survival. Despite a high unmet
Autor:
Berangere, Gapp, Marie, Jourdain, Pauline, Bringer, Benjamin, Kueng, Delphine, Weber, Arnaud, Osmont, Stefan, Zurbruegg, Judith, Knehr, Rocco, Falchetto, Guglielmo, Roma, William, Dietrich, Reginald, Valdez, Nicolau, Beckmann, Florian, Nigsch, Arun J, Sanyal, Iwona, Ksiazek
Publikováno v:
Hepatology Communications
A promising approach for the treatment of nonalcoholic steatohepatitis (NASH) is the inhibition of enhanced hepatic de novo lipogenesis (DNL), which is the synthesis of fatty acids from nonlipid sources. This study assesses three approaches to DNL su
Autor:
Shinji Hatakeyama, Marie Jourdain
Publikováno v:
BMC Research Notes, Vol 12, Iss 1, Pp 1-4 (2019)
BMC Research Notes
BMC Research Notes
Objective 5-HOB is a novel tissue selective, 5-hydroxybenzothiazolone-derived β2 adrenoceptor agonist with minimized cardiovascular effects while retaining efficacy on skeletal muscle in preclinical experiments unlike conventional β2 adrenoceptor a
Autor:
De Muizon, Marie Jourdain1,2 muizon@strw.leidenuniv.nl
Publikováno v:
Space Science Reviews. Jul2005, Vol. 119 Issue 1-4, p201-214. 14p. 1 Chart, 2 Graphs.
Autor:
Caroline Boesch, Marie Jourdain, Markus Hecker, Christian Bronner, Valérie B. Schini-Kerth, Murielle Zerr-Fouineau
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 29:586-593
Objectives— Estro-progestin treatments have been associated with an increased risk of thromboembolic events in postmenopausal women. This study examined whether progestins affect the stimulatory effect of estrogens on the endothelial formation of n